“grail” Archives

in
Entry Author Date Location
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal 09/21/20 San Francisco
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue 09/09/20 National
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Thrive Adds $257M, Plans Pivotal Trial of Early Cancer Detection Test 07/29/20 National
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Grail Plants a Seed in RTP, Pledges $100M Investment in New Site 06/02/20 Raleigh Durham
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow 11/20/19 San Francisco
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More 10/11/19 National
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection 07/24/19 San Francisco
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Grail’s Cook Steps Down, Former Juno Executive Bishop Named CEO 06/06/19 San Francisco
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target 03/13/19 San Diego
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Seer Launches to Develop Liquid Biopsy for Cancer, Brain Disease 12/17/18 San Francisco
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Guardant Health’s IPO Tops Range, Raising $238M for Cancer Tests 10/04/18 San Francisco
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
A.I. for Healthcare Gets Even More Crowded as GV Invests in Owkin 05/23/18 New York
With $300M in New Round, Total Venture Funding at Grail Tops $1.5B 05/22/18 San Diego
Verdine Picks Backers For FogPharma’s $66M Round, Keeping Firm Control 05/16/18 Boston
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More 03/02/18 National
Page 1 of 2 next page »